| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | Director | Stock Options (Right to buy) | 35,000 | $779,800 | $22.28 | 15 May 2024 | Direct |
| Syndax Pharmaceuticals Inc | Director | Common Stock | 25,000 | $500,745 | $20.03 | 05 Feb 2025 | Direct |
| GERON CORP | EVP, Chief Medical Officer | Employee Stock Option (right to buy) | 750,000 | 16 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 05 Feb 2025 | 1 | $0 | 4 | Director | 07 Feb 2025, 16:39 |
| SNDX | Syndax Pharmaceuticals Inc | 15 May 2024 | 1 | $0 | 4 | Director | 16 May 2024, 16:04 |
| SNDX | Syndax Pharmaceuticals Inc | 15 May 2024 | 0 | $0 | 3 | Director | 16 May 2024, 16:03 |
| GERN | GERON CORP | 16 Feb 2022 | 1 | $0 | 4 | EVP, Chief Medical Officer | 18 Feb 2022, 17:05 |